IN-VITRO IMMUNOMODULATORY EFFECTS OF PENTOXIFYLLINE

被引:59
作者
RIENECK, K
DIAMANT, M
HAAHR, PM
SCHONHARTING, M
BENDTZEN, K
机构
[1] RIGSHOSP, DEPT MED TTA 7544, MED IMMUNOL LAB, DK-2200 COPENHAGEN N, DENMARK
[2] RIGSHOSP, DEPT INFECT DIS, DK-2200 COPENHAGEN N, DENMARK
[3] HOECHST AG, W-6200 WIESBADEN 1, GERMANY
关键词
D O I
10.1016/0165-2478(93)90022-T
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pentoxifylline (PTX), a methylxanthine derivative and phosphodiesterase inhibitor, is known to influence production and/or function of some cytokines. We examined the effect of PTX on the in vitro expression of cytokine genes using endotoxin- or phytohaemagglutinin (PHA)-stimulated human blood mononuclear cells. The expression of tumour necrosis factor (TNF)alpha, TNFbeta interleukin (IL)-2 and interferon (IFN)gamma was inhibited by PTX in a dose-dependent manner, whereas expression of IL-1alpha, IL-1beta, and IL-6 was unaffected at concentrations up to 300 muM of PTX. The amount of TNFbeta mRNA in PHA-stimulated blood mononuclear cells was reduced by PTX. Finally, PTX stimulated PHA-induced cell proliferation whereas antigen-induced cel proliferation was inhibited in the presence of PTX. The PTX analogues HWA-138 and A-802715 inhibited TNFalpha mRNA expression from endotoxin-stimulated mononuclear cells. These data suggest that PTX-analogues affect the in vitro immune response at different target points and that the response depends upon the respective triggering mechanism(s).
引用
收藏
页码:131 / 138
页数:8
相关论文
共 42 条
[1]   EVIDENCE THAT PENTOXIFYLLINE REDUCES ANTI-CD3 MONOCLONAL ANTIBODY-INDUCED CYTOKINE RELEASE SYNDROME [J].
ALEGRE, ML ;
GASTALDELLO, K ;
ABRAMOWICZ, D ;
KINNAERT, P ;
VEREERSTRAETEN, P ;
DEPAUW, L ;
VANDENABEELE, P ;
MOSER, M ;
LEO, O ;
GOLDMAN, M .
TRANSPLANTATION, 1991, 52 (04) :674-679
[2]   PENTOXIFYLLINE INHIBITS CERTAIN CONSTITUTIVE AND TUMOR NECROSIS FACTOR-ALPHA-INDUCED ACTIVITIES OF HUMAN NORMAL DERMAL FIBROBLASTS [J].
BERMAN, B ;
WIETZERBIN, J ;
SANCEAU, J ;
MERLIN, G ;
DUNCAN, MR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (05) :706-712
[3]   EFFECT OF PENTOXIFYLLINE ON THE PHAGOCYTIC-ACTIVITY, CAMP LEVELS, AND SUPEROXIDE ANION PRODUCTION BY MONOCYTES AND POLYMORPHONUCLEAR CELLS [J].
BESSLER, H ;
GILGAL, R ;
DJALDETTI, M ;
ZAHAVI, I .
JOURNAL OF LEUKOCYTE BIOLOGY, 1986, 40 (06) :747-754
[4]   CYTOKINE RELEASE FROM MICROGLIA - DIFFERENTIAL INHIBITION BY PENTOXIFYLLINE AND DEXAMETHASONE [J].
CHAO, CC ;
HU, SX ;
CLOSE, K ;
CHOI, CS ;
MOLITOR, TW ;
NOVICK, WJ ;
PETERSON, PK .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (04) :847-853
[5]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[6]   PHARMACOLOGICAL MODULATION OF INTERLEUKIN-1 EXPRESSION BY AMPHOTERICIN B-STIMULATED HUMAN MONONUCLEAR-CELLS [J].
CLEARY, JD ;
CHAPMAN, SW ;
NOLAN, RL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) :977-981
[7]   DOWN-REGULATION OF TUMOR-NECROSIS-FACTOR EXPRESSION BY PENTOXIFYLLINE IN CANCER-PATIENTS - A PILOT-STUDY [J].
DEZUBE, BJ ;
SHERMAN, ML ;
FRIDOVICHKEIL, JL ;
ALLENRYAN, J ;
PARDEE, AB .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (01) :57-60
[8]  
DOHERTY GM, 1991, SURGERY, V110, P192
[9]   PENTOXIFYLLINE INHIBITS INTERLEUKIN-2-INDUCED TOXICITY IN C57BL/6 MICE BUT PRESERVES ANTITUMOR EFFICACY [J].
EDWARDS, MJ ;
HENIFORD, BT ;
KLAR, EA ;
DOAK, KW ;
MILLER, FN .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) :637-641
[10]  
ENDRES S, 1991, IMMUNOLOGY, V72, P56